Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 139Neoplasms 118Prostatic Neoplasms 64Lung Neoplasms 48Head and Neck Neoplasms 46Colorectal Neoplasms 38Ovarian Neoplasms 33Uterine Cervical Neoplasms 29Endometrial Neoplasms 23Motor Activity 22Neoplasm Metastasis 20Multiple Myeloma 20Pancreatic Neoplasms 19Brain Neoplasms 19Rectal Neoplasms 18Lymphoma 17Colonic Neoplasms 17Pain 16Gastrointestinal Neoplasms 16Fatigue 16Carcinoma, Non-Small-Cell Lung 16Leukemia 15Depression 15Oropharyngeal Neoplasms 13Melanoma 13Anxiety Disorders 13Urinary Bladder Neoplasms 12Hematologic Neoplasms 12Esophageal Neoplasms 12Stomach Neoplasms 11

Interventions

pembrolizumab 3Paclitaxel 2relatlimab 1nintedanib 1lifileucel 1dabrafenib 1Vitamin D 1Temozolomide 1Surveys and Questionnaires 1Opdualag 1Nivolumab 1Microarray Analysis 1Ipilimumab 1Genetic Testing 1Gene Expression Profiling 1Eye Movement Desensitization Reprocessing 1Electrochemotherapy 1Dacarbazine 1Cholecalciferol 1Carboplatin 1Biopsy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma, Cutaneous Malignant × Surveys and Questionnaires × Clear all
NCT00816374 2014-05-16

Tailored Intervention for Melanoma Patient's Families

Fox Chase Cancer Center

Phase NA Completed
553 enrolled
Dermatologic

Melanoma, Cutaneous Malignant, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡